No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: Results from a community-based study

Arthritis and Rheumatism

Volumn 50, Issue 11, 2004, Pages 3729-3731

  Turesson, Carl ^a,b   McClelland, Robyn L ^a   Christianson, Teresa J H ^a   Matteson, Eric L ^a  

^a Mayo Clinic   (United States)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR;

ARTICLE; CARDIOVASCULAR DISEASE; FELTY SYNDROME; HUMAN; INCIDENCE; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; NEUROPATHY; PERICARDITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SJOEGREN SYNDROME; SURVIVAL; VASCULITIS;

ARTHRITIS, RHEUMATOID; HUMANS; INCIDENCE; MINNESOTA; TIME FACTORS; VASCULITIS;

EID: 8444235997     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20590     Document Type: Article

References (11)

1. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002;29:62-7.
2. Gordon DA, Stein JL, Broder I. The extra-articular features of rheumatoid arthritis: a systematic analysis of 127 cases. Am J Med 1973;54:445-52.
3. Turesson C, Jacobsson L, Bergstrom U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford) 1999;38:668-74.
4. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 2003;62:722-7.
5. Watts RA, Mooney J, Lane SE, Scott DG. Systemic rheumatoid vasculitis-following the dodo? [abstract]. Arthritis Rheum 2003;48 Suppl 9:S109.
6. Doran MF, Pond GR, Crowson CS, O'Fallon WM, Gabriel SE. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 2002;46:625-31.
7. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators [review]. Stat Med 1999;18:695-706.
8. Gabriel SE, Crowson CS, Kremers HM, Doran MF, Turesson C, O'Fallon WM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum 2003;48:54-8.
9. Turesson C, Jacobsson LT. Epidemiology of extra-articular manifestations in rheumatoid arthritis [review]. Scand J Rheumatol 2004;33:65-72.
10. Bergstrom U, Book C, Lindroth Y, Marsal L, Saxne T, Jacobsson L. Lower disease activity and disability in Swedish patients with rheumatoid arthritis in 1995 compared with 1978. Scand J Rheumatol 1999;28:160-5.
11. Jarrett SJ, Cunnane G, Conaghan PG, Bingham SJ, Buch MH, Quinn MA, et al. Anti-tumor necrosis factor-α therapy-induced vasculitis: case series. J Rheumatol 2003;30:2287-91.